The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharmaceutical Contract Manufacturing and Contract Market Research Report 2024
Synopsis
Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
The global Pharmaceutical Contract Manufacturing and Contract market was valued at US$ 87830 million in 2023 and is anticipated to reach US$ 136290 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
North America is the largest consumption place, with a consumption market share nearly 35% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 23%.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Contract Manufacturing and Contract, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Contract Manufacturing and Contract.
Report Scope
The Pharmaceutical Contract Manufacturing and Contract market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Contract Manufacturing and Contract market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Contract Manufacturing and Contract companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
Thermo Fisher Scientific
Lonza
Boehringer Ingelheim
Fareva
Recipharm
Aenova
AbbVie
Baxter
Nipro Corp
Sopharma
Famar
Vetter
Shandong Xinhua
Piramal
Mylan
Dr. Reddy’s
Zhejiang Hisun
Zhejiang Huahai
Jubilant
Segment by Type
Oral
Injectable
API
Other
Segment by Application
Small Medium Enterprise
Large Enterprise
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Contract Manufacturing and Contract companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
The global Pharmaceutical Contract Manufacturing and Contract market was valued at US$ 87830 million in 2023 and is anticipated to reach US$ 136290 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
North America is the largest consumption place, with a consumption market share nearly 35% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 23%.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Contract Manufacturing and Contract, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Contract Manufacturing and Contract.
Report Scope
The Pharmaceutical Contract Manufacturing and Contract market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Contract Manufacturing and Contract market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Contract Manufacturing and Contract companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
Thermo Fisher Scientific
Lonza
Boehringer Ingelheim
Fareva
Recipharm
Aenova
AbbVie
Baxter
Nipro Corp
Sopharma
Famar
Vetter
Shandong Xinhua
Piramal
Mylan
Dr. Reddy’s
Zhejiang Hisun
Zhejiang Huahai
Jubilant
Segment by Type
Oral
Injectable
API
Other
Segment by Application
Small Medium Enterprise
Large Enterprise
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Contract Manufacturing and Contract companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Injectable
1.2.4 API
1.2.5 Other
1.3 Market by Application
1.3.1 Global Pharmaceutical Contract Manufacturing and Contract Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Small Medium Enterprise
1.3.3 Large Enterprise
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Contract Manufacturing and Contract Market Perspective (2019-2030)
2.2 Pharmaceutical Contract Manufacturing and Contract Growth Trends by Region
2.2.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical Contract Manufacturing and Contract Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutical Contract Manufacturing and Contract Market Dynamics
2.3.1 Pharmaceutical Contract Manufacturing and Contract Industry Trends
2.3.2 Pharmaceutical Contract Manufacturing and Contract Market Drivers
2.3.3 Pharmaceutical Contract Manufacturing and Contract Market Challenges
2.3.4 Pharmaceutical Contract Manufacturing and Contract Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Contract Manufacturing and Contract Players by Revenue
3.1.1 Global Top Pharmaceutical Contract Manufacturing and Contract Players by Revenue (2019-2024)
3.1.2 Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical Contract Manufacturing and Contract Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Contract Manufacturing and Contract Revenue
3.4 Global Pharmaceutical Contract Manufacturing and Contract Market Concentration Ratio
3.4.1 Global Pharmaceutical Contract Manufacturing and Contract Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Manufacturing and Contract Revenue in 2023
3.5 Pharmaceutical Contract Manufacturing and Contract Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Contract Manufacturing and Contract Product Solution and Service
3.7 Date of Enter into Pharmaceutical Contract Manufacturing and Contract Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Contract Manufacturing and Contract Breakdown Data by Type
4.1 Global Pharmaceutical Contract Manufacturing and Contract Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Type (2025-2030)
5 Pharmaceutical Contract Manufacturing and Contract Breakdown Data by Application
5.1 Global Pharmaceutical Contract Manufacturing and Contract Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical Contract Manufacturing and Contract Market Size (2019-2030)
6.2 North America Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2019-2024)
6.4 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Contract Manufacturing and Contract Market Size (2019-2030)
7.2 Europe Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2019-2024)
7.4 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size (2019-2030)
8.2 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size (2019-2030)
9.2 Latin America Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2019-2024)
9.4 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size (2019-2030)
10.2 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Detail
11.1.2 Catalent Business Overview
11.1.3 Catalent Pharmaceutical Contract Manufacturing and Contract Introduction
11.1.4 Catalent Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.1.5 Catalent Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Introduction
11.2.4 Thermo Fisher Scientific Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Lonza
11.3.1 Lonza Company Detail
11.3.2 Lonza Business Overview
11.3.3 Lonza Pharmaceutical Contract Manufacturing and Contract Introduction
11.3.4 Lonza Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.3.5 Lonza Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Detail
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Introduction
11.4.4 Boehringer Ingelheim Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Fareva
11.5.1 Fareva Company Detail
11.5.2 Fareva Business Overview
11.5.3 Fareva Pharmaceutical Contract Manufacturing and Contract Introduction
11.5.4 Fareva Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.5.5 Fareva Recent Development
11.6 Recipharm
11.6.1 Recipharm Company Detail
11.6.2 Recipharm Business Overview
11.6.3 Recipharm Pharmaceutical Contract Manufacturing and Contract Introduction
11.6.4 Recipharm Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.6.5 Recipharm Recent Development
11.7 Aenova
11.7.1 Aenova Company Detail
11.7.2 Aenova Business Overview
11.7.3 Aenova Pharmaceutical Contract Manufacturing and Contract Introduction
11.7.4 Aenova Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.7.5 Aenova Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Pharmaceutical Contract Manufacturing and Contract Introduction
11.8.4 AbbVie Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.8.5 AbbVie Recent Development
11.9 Baxter
11.9.1 Baxter Company Detail
11.9.2 Baxter Business Overview
11.9.3 Baxter Pharmaceutical Contract Manufacturing and Contract Introduction
11.9.4 Baxter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.9.5 Baxter Recent Development
11.10 Nipro Corp
11.10.1 Nipro Corp Company Detail
11.10.2 Nipro Corp Business Overview
11.10.3 Nipro Corp Pharmaceutical Contract Manufacturing and Contract Introduction
11.10.4 Nipro Corp Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.10.5 Nipro Corp Recent Development
11.11 Sopharma
11.11.1 Sopharma Company Detail
11.11.2 Sopharma Business Overview
11.11.3 Sopharma Pharmaceutical Contract Manufacturing and Contract Introduction
11.11.4 Sopharma Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.11.5 Sopharma Recent Development
11.12 Famar
11.12.1 Famar Company Detail
11.12.2 Famar Business Overview
11.12.3 Famar Pharmaceutical Contract Manufacturing and Contract Introduction
11.12.4 Famar Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.12.5 Famar Recent Development
11.13 Vetter
11.13.1 Vetter Company Detail
11.13.2 Vetter Business Overview
11.13.3 Vetter Pharmaceutical Contract Manufacturing and Contract Introduction
11.13.4 Vetter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.13.5 Vetter Recent Development
11.14 Shandong Xinhua
11.14.1 Shandong Xinhua Company Detail
11.14.2 Shandong Xinhua Business Overview
11.14.3 Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Introduction
11.14.4 Shandong Xinhua Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.14.5 Shandong Xinhua Recent Development
11.15 Piramal
11.15.1 Piramal Company Detail
11.15.2 Piramal Business Overview
11.15.3 Piramal Pharmaceutical Contract Manufacturing and Contract Introduction
11.15.4 Piramal Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.15.5 Piramal Recent Development
11.16 Mylan
11.16.1 Mylan Company Detail
11.16.2 Mylan Business Overview
11.16.3 Mylan Pharmaceutical Contract Manufacturing and Contract Introduction
11.16.4 Mylan Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.16.5 Mylan Recent Development
11.17 Dr. Reddy’s
11.17.1 Dr. Reddy’s Company Detail
11.17.2 Dr. Reddy’s Business Overview
11.17.3 Dr. Reddy’s Pharmaceutical Contract Manufacturing and Contract Introduction
11.17.4 Dr. Reddy’s Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.17.5 Dr. Reddy’s Recent Development
11.18 Zhejiang Hisun
11.18.1 Zhejiang Hisun Company Detail
11.18.2 Zhejiang Hisun Business Overview
11.18.3 Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Introduction
11.18.4 Zhejiang Hisun Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.18.5 Zhejiang Hisun Recent Development
11.19 Zhejiang Huahai
11.19.1 Zhejiang Huahai Company Detail
11.19.2 Zhejiang Huahai Business Overview
11.19.3 Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Introduction
11.19.4 Zhejiang Huahai Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.19.5 Zhejiang Huahai Recent Development
11.20 Jubilant
11.20.1 Jubilant Company Detail
11.20.2 Jubilant Business Overview
11.20.3 Jubilant Pharmaceutical Contract Manufacturing and Contract Introduction
11.20.4 Jubilant Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2019-2024)
11.20.5 Jubilant Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
